B
Bull
Bull · 25%EXPO
$68.96
Precio del escenario
$70.300
-0.703 (-1.00%)Al cierre
Loading chart…
- High
- 71.340
- Open
- 70.960
- VWAP
- 70.29
- Vol
- 382.95K
- Mkt Cap
- 4.85B
- Low
- 69.230
- Amount
- 26.92M
- EV/EBITDA, TTM
- 25.28
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
AI analysis of Exponent Inc (EXPO)
buyExponent Inc is a good buy right now due to its strong recent performance with a current price of $71.53, a gross margin of 100%, and an anticipated revenue growth of 9% to 10% for the fiscal year 2026. The main risk is its RSI of 73.815, indicating it may be overbought in the short term.
Analyst Ratings (4)
+21.62% upside
Hold
1 Buy
3 Hold
0 Sell
Current: 70.30
Mínimo
81.00
Promedio
85.50
Máximo
90.00
UBS
Neutral
$72
2026-07-31
UBS
2026-07-31
Precio objetivo
$72
Neutral
JPMorgan
Overweight
$90
2026-07-31
JPMorgan
2026-07-31
Precio objetivo
$90
Overweight
JPMorgan
Overweight
$80
2026-05-15
JPMorgan
2026-05-15
Precio objetivo
$80
Overweight
UBS
Neutral
$75
2026-05-01
UBS
2026-05-01
Precio objetivo
$75
Neutral
JPMorgan
Overweight
$95
2026-03-26
JPMorgan
2026-03-26
Precio objetivo
$95
Overweight
Métricas de valoración
The current forward P/E ratio for Exponent Inc (EXPO) is 29.33, compared to its 5-year average forward P/E of 43.48.
Alphio AI Price Scenarios for EXPO
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding EXPO
Cronología de eventos
Noticias
8.508-11Yahoo FinanceH&MV Engineering Secures €750 Million Investment for U.S. Expansion
9.507-31seekingalphaExponent Reports Strong Q2 2026 Earnings Growth Driven by AI Demand
- 9.507-30seekingalpha
Exponent Q2 Earnings Exceed Expectations
5.007-19FoolCEO Catherine Corrigan Sells Shares of Exponent, Inc.
5.007-19NASDAQ.COMExponent CEO's Stock Sale Raises Eyebrows
EXPO FAQ — answered by Alphio AI
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).
Exponent Inc is a good buy right now due to its strong recent performance with a current price of $71.53, a gross margin of 100%, and an anticipated revenue growth of 9% to 10% for the fiscal year 2026. The main risk is its RSI of 73.815, indicating it may be overbought in the short term.
4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.